Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 2
|
pp. 1879–1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Back to article
Figure 5
(5 of 11)
−
100%
+
Figure 5.
Gene alteration of CDK16.
(
A
) The mutation and CNA status of CDK16 in TCGA-pan-cancer. (
B
) The correlation between CDK16 expression and CNA.
